![IJMS | Free Full-Text | MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers IJMS | Free Full-Text | MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers](https://www.mdpi.com/ijms/ijms-22-04072/article_deploy/html/images/ijms-22-04072-g001.png)
IJMS | Free Full-Text | MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers
![Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications | SpringerLink Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-017-0772-1/MediaObjects/12282_2017_772_Fig2_HTML.gif)
Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications | SpringerLink
![SciELO - Brasil - Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review SciELO - Brasil - Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review](https://minio.scielo.br/documentstore/1806-9282/cgqkqKK5YRcm876kw5STgfF/2586a9e001265378d80086f34d87b3a0ac5a1c4d.jpg)
SciELO - Brasil - Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review
View of AROMATASE INHIBITORS - TYPES AND ADVANTAGES | International Journal of Pharmacy and Pharmaceutical Sciences
![IJMS | Free Full-Text | Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective IJMS | Free Full-Text | Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective](https://www.mdpi.com/ijms/ijms-22-07812/article_deploy/html/images/ijms-22-07812-g001.png)
IJMS | Free Full-Text | Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective
![Figure 4 from Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review. | Semantic Scholar Figure 4 from Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6a29d58a8f49f38a9156c5c3c9369190911bce97/4-Figure4-1.png)
Figure 4 from Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review. | Semantic Scholar
![Cureus | Hormone Receptor Down-Regulation in Metastatic Breast Cancer After Endocrine Therapy Detected in Oophorectomy: A Case Report and Review of Literature | Media Cureus | Hormone Receptor Down-Regulation in Metastatic Breast Cancer After Endocrine Therapy Detected in Oophorectomy: A Case Report and Review of Literature | Media](https://assets.cureus.com/uploads/figure/file/274206/lightbox_3421e82044a611ec876de324da9087e0-Fig.11.png)
Cureus | Hormone Receptor Down-Regulation in Metastatic Breast Cancer After Endocrine Therapy Detected in Oophorectomy: A Case Report and Review of Literature | Media
![Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer - ScienceDirect Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0093775403003026-gr1.gif)